Company ProfilePremium

AngioDynamics

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
AngioDynamics - Healthcare showcase

Year Founded & Workforce

1988

1,200 Employees

Industry

Healthcare

Services

Tumor Ablation
A

AngioDynamics Employee Contacts

40 verified contactsNames, job titles, seniority and locations

View Employee Contacts

AngioDynamics Overview

Company Headquarters: New York, US

Founded: 1988

Workforce: ~1,200

Company Working: AngioDynamics manufactures disruptive and innovative medical devices. The company provides vital tools to healthcare professionals around the world. It reaches over 50 markets via direct sales and distributors. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. AngioDynamics has operating facilities in Europe, the US, Asia, and Latin America.

Strategy

AngioDynamics is concentrating on providing a comprehensive, customer-driven service and selling consistently high-quality products at a market-conscious price level. It is investing in R&D to innovate and deliver better treatment options. It is also focusing on the expansion of the company in the new market.

Company Snapshot

$270.6M

Revenue

1,200

Employees

1988

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

  • Reach in over 50 markets via direct sales and distribution
  • High-quality products & services
  • Strong R&D team

Weaknesses

  • Decrease in revenue generation

Opportunities

  • Product portfolio diversification
  • Scope for mergers & acquisitions
  • Expansion in emerging markets

Threats

  • Changes in foreign currency exchange rates

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • AngioDynamics
    • Tumor Ablation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 270.6 Mn in 2019 to USD 291 Mn in 2021.
AngioDynamics — By Business Segment
Series (USD Mn)201920202021
Sales270.6264.2291
R&D Expenditure28.329.736.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.